NYU Laura and Isaac Perlmutter Cancer Center SC

New York, New York 10016

Use our guide to learn which trials are right for you!

We've found
1 trials
at this facility
Melanoma Clinical Trial
A Study of the Anti-PD1 Antibody PDR001, in Combination With Dabrafenib and Trametinib in Advanced Melanoma
Status: Enrolling, Phase III
Updated: 12/31/1969
NYU Laura and Isaac Perlmutter Cancer Center SC
mi
from
New York, NY
Click here to add this to my saved trials